Anoikis molecular pathways and its role in cancer progression

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 12, 2013, Pages 3481-3498

  Paoli, Paolo ^a   Giannoni, Elisa ^a   Chiarugi, Paola ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b ISTITUTO TOSCANO TUMORI   (Italy)

Author keywords

Anoikis; Cancer; Metabolism; MicroRNA; Reactive oxygen species

Indexed keywords

BH3 PROTEIN; CASPASE 8; CASPASE 9; CYTOCHROME C; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; DEATH RECEPTOR; FLICE INHIBITORY PROTEIN; GROWTH FACTOR RECEPTOR; INTEGRIN; MICRORNA; PROTEIN BAX; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VOLTAGE DEPENDENT ANION CHANNEL;

ANOIKIS; AUTOPHAGY; CANCER CELL; CANCER GROWTH; CELL ADHESION; CELL COMMUNICATION; CELL DEATH; CELL MIGRATION; CELL PROTECTION; CELL SURVIVAL; DNA FRAGMENTATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE ACTIVATION; GENE MUTATION; ONCOGENE; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SURVIVAL FACTOR; TUMOR MICROENVIRONMENT;

EID: 84887621878     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.06.026     Document Type: Review

References (266)

1. Alahari S.K., Reddig P.J., Juliano R.L. Biological aspects of signal transduction by cell adhesion receptors. Int. Rev. Cytol. 2002, 220:145-184.
2. Altomare D.A., Testa J.R. Perturbations of the AKT signaling pathway in human cancer. Oncogene 2005, 24:7455-7464.
3. Anastasiou D., Poulogiannis G., Asara J.M., Boxer M.B., Jiang J.K., Shen M., Bellinger G., Sasaki A.T., Locasale J.W., Auld D.S., Thomas C.J., Vander Heiden M.G., Cantley L.C. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 2011, 334:1278-1283.
4. Aoudjit F., Vuori K. Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-flip and implications for anoikis. J. Cell Biol. 2001, 152:633-643.
5. Attwell S., Roskelley C., Dedhar S. The integrin-linked kinase (ILK) suppresses anoikis. Oncogene 2000, 19:3811-3815.
6. Avivar-Valderas A., Bobrovnikova-Marjon E., Alan D.J., Bardeesy N., Debnath J., Aguirre-Ghiso J.A. Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK. Oncogene 2012.
7. Avivar-Valderas A., Salas E., Bobrovnikova-Marjon E., Diehl J.A., Nagi C., Debnath J., Aguirre-Ghiso J.A. PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. Mol. Cell Biol. 2011, 31:3616-3629.
8. Avizienyte E., Frame M.C. Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr. Opin. Cell Biol. 2005, 17:542-547.
9. Barberis L., Wary K.K., Fiucci G., Liu F., Hirsch E., Brancaccio M., Altruda F., Tarone G., Giancotti F.G. Distinct roles of the adaptor protein Shc and focal adhesion kinase in integrin signaling to ERK. J. Biol. Chem. 2000, 275:36532-36540.
10. Barnett P., Arnold R.S., Mezencev R., Chung L.W., Zayzafoon M., Odero-Marah V. Snail-mediated regulation of reactive oxygen species in ARCaP human prostate cancer cells. Biochem. Biophys. Res. Commun. 2011, 404:34-39.
11. Barrallo-Gimeno A., Nieto M.A. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005, 132:3151-3161.
12. Baum B., Settleman J., Quinlan M.P. Transitions between epithelial and mesenchymal states in development and disease. Semin. Cell Dev. Biol. 2008, 19:294-308.
13. Beggs H.E., Baragona S.C., Hemperly J.J., Maness P.F. NCAM140 interacts with the focal adhesion kinase p125(fak) and the SRC-related tyrosine kinase p59(fyn). J. Biol. Chem. 1997, 272:8310-8319.
14. Belzacq A.S., Vieira H.L., Kroemer G., Brenner C. The adenine nucleotide translocator in apoptosis. Biochimie 2002, 84:167-176.
15. Benvenuti S., Comoglio P.M. The MET receptor tyrosine kinase in invasion and metastasis. J. Cell. Physiol. 2007, 213:316-325.
16. Berezovskaya O., Schimmer A.D., Glinskii A.B., Pinilla C., Hoffman R.M., Reed J.C., Glinsky G.V. Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. Cancer Res. 2005, 65:2378-2386.
17. Bergin E., Levine J.S., Koh J.S., Lieberthal W. Mouse proximal tubular cell-cell adhesion inhibits apoptosis by a cadherin-dependent mechanism. Am. J. Physiol. Renal Physiol. 2000, 278:F758-F768.
18. Biroccio A., Benassi B., Filomeni G., Amodei S., Marchini S., Chiorino G., Rotilio G., Zupi G., Ciriolo M.R. Glutathione influences c-Myc-induced apoptosis in M14 human melanoma cells. J. Biol. Chem. 2002, 277:43763-43770.
19. Blanco M.J., Moreno-Bueno G., Sarrio D., Locascio A., Cano A., Palacios J., Nieto M.A. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002, 21:3241-3246.
20. Bon G., Folgiero V., Bossi G., Felicioni L., Marchetti A., Sacchi A., Falcioni R. Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation. Clin. Cancer Res. 2006, 12:3280-3287.
21. Bonni A., Brunet A., West A.E., Datta S.R., Takasu M.A., Greenberg M.E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999, 286:1358-1362.
22. Bottcher R.T., Lange A., Fassler R. How ILK and kindlins cooperate to orchestrate integrin signaling. Curr. Opin. Cell Biol. 2009, 21:670-675.
23. Bouchard V., Demers M.J., Thibodeau S., Laquerre V., Fujita N., Tsuruo T., Beaulieu J.F., Gauthier R., Vezina A., Villeneuve L., Vachon P.H. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways. J. Cell. Physiol. 2007, 212:717-728.
24. Boudreau N.J., Jones P.L. Extracellular matrix and integrin signalling: the shape of things to come. Biochem. J. 1999, 339(Pt 3):481-488.
25. Bouillet P., Strasser A. BH3-only proteins - evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J. Cell Sci. 2002, 115:1567-1574.
26. Boya P., Gonzalez-Polo R.A., Casares N., Perfettini J.L., Dessen P., Larochette N., Metivier D., Meley D., Souquere S., Yoshimori T., Pierron G., Codogno P., Kroemer G. Inhibition of macroautophagy triggers apoptosis. Mol. Cell Biol. 2005, 25:1025-1040.
27. Boyer B., Roche S., Denoyelle M., Thiery J.P. Src and Ras are involved in separate pathways in epithelial cell scattering. EMBO J. 1997, 16:5904-5913.
28. Brahimi-Horn M.C., Chiche J., Pouyssegur J. Hypoxia signalling controls metabolic demand. Curr. Opin. Cell Biol. 2007, 19:223-229.
29. Brassard D.L., Maxwell E., Malkowski M., Nagabhushan T.L., Kumar C.C., Armstrong L. Integrin alpha(v)beta(3)-mediated activation of apoptosis. Exp. Cell Res. 1999, 251:33-45.
30. Bravou V., Klironomos G., Papadaki E., Taraviras S., Varakis J. ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway. J. Pathol. 2006, 208:91-99.
31. Brenner B., Gulbins E., Schlottmann K., Koppenhoefer U., Busch G.L., Walzog B., Steinhausen M., Coggeshall K.M., Linderkamp O., Lang F. L-selectin activates the Ras pathway via the tyrosine kinase p56lck. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:15376-15381.
32. Breuss J.M., Gallo J., DeLisser H.M., Klimanskaya I.V., Folkesson H.G., Pittet J.F., Nishimura S.L., Aldape K., Landers D.V., Carpenter W. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J. Cell Sci. 1995, 108(Pt 6):2241-2251.
33. Brown D.I., Griendling K.K. Nox proteins in signal transduction. Free Radic. Biol. Med. 2009, 47:1239-1253.
34. Buchheit C.L., Rayavarapu R.R., Schafer Z.T. The regulation of cancer cell death and metabolism by extracellular matrix attachment. Semin. Cell Dev. Biol. 2012, 23:402-411.
35. Cairns R.A., Harris I.S., Mak T.W. Regulation of cancer cell metabolism. Nat. Rev. Cancer 2011, 11:85-95.
36. Calalb M.B., Polte T.R., Hanks S.K. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol. Cell Biol. 1995, 15:954-963.
37. Camps C., Buffa F.M., Colella S., Moore J., Sotiriou C., Sheldon H., Harris A.L., Gleadle J.M., Ragoussis J. Hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin. Cancer Res. 2008, 14:1340-1348.
38. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., Frisch S., Reed J.C. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998, 282:1318-1321.
39. Cavallaro U., Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 2004, 4:118-132.
40. Chen C., Pore N., Behrooz A., Ismail-Beigi F., Maity A. Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J. Biol. Chem. 2001, 276:9519-9525.
41. Chen C.S., Mrksich M., Huang S., Whitesides G.M., Ingber D.E. Geometric control of cell life and death. Science 1997, 276:1425-1428.
42. Chen H.C., Appeddu P.A., Isoda H., Guan J.L. Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. J. Biol. Chem. 1996, 271:26329-26334.
43. Chen X., Lingala S., Khoobyari S., Nolta J., Zern M.A., Wu J. Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations. J. Hepatol. 2011, 55:838-845.
44. Chen Y., McMillan-Ward E., Kong J., Israels S.J., Gibson S.B. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ. 2008, 15:171-182.
45. Cheng E.H., Wei M.C., Weiler S., Flavell R.A., Mak T.W., Lindsten T., Korsmeyer S.J. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell 2001, 8:705-711.
46. Chiarugi P., Buricchi F. Protein tyrosine phosphorylation and reversible oxidation: two cross-talking posttranslation modifications. Antioxid. Redox Signal. 2007, 9:1-24.
47. Chiarugi P., Giannoni E. Anoikis: a necessary death program for anchorage-dependent cells. Biochem. Pharmacol. 2008, 76:1352-1364.
48. Cohen G.M. Caspases: the executioners of apoptosis. Biochem. J. 1997, 326(Pt 1):1-16.
49. Collins N.L., Reginato M.J., Paulus J.K., Sgroi D.C., Labaer J., Brugge J.S. G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression. Mol. Cell Biol. 2005, 25:5282-5291.
50. Cosse J.P., Sermeus A., Vannuvel K., Ninane N., Raes M., Michiels C. Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines. Mol. Cancer 2007, 6:61.
51. Crouch D.H., Fincham V.J., Frame M.C. Targeted proteolysis of the focal adhesion kinase pp 125 FAK during c-MYC-induced apoptosis is suppressed by integrin signalling. Oncogene 1996, 12:2689-2696.
52. Dang C.V., Kim J.W., Gao P., Yustein J. The interplay between MYC and HIF in cancer. Nat. Rev. Cancer 2008, 8:51-56.
53. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91:231-241.
54. Datta S.R., Katsov A., Hu L., Petros A., Fesik S.W., Yaffe M.B., Greenberg M.E. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol. Cell 2000, 6:41-51.
55. Davies M.A., Koul D., Dhesi H., Berman R., McDonnell T.J., McConkey D., Yung W.K., Steck P.A. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res. 1999, 59:2551-2556.
56. del P.L., Gonzalez-Garcia M., Page C., Herrera R., Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997, 278:687-689.
57. Denicola G.M., Karreth F.A., Humpton T.J., Gopinathan A., Wei C., Frese K., Mangal D., Yu K.H., Yeo C.J., Calhoun E.S., Scrimieri F., Winter J.M., Hruban R.H., Iacobuzio-Donahue C., Kern S.E., Blair I.A., Tuveson D.A. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011, 475:106-109.
58. Denko N.C. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat. Rev. Cancer 2008, 8:705-713.
59. Dong Z., Venkatachalam M.A., Wang J., Patel Y., Saikumar P., Semenza G.L., Force T., Nishiyama J. Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanisms. J. Biol. Chem. 2001, 276:18702-18709.
60. Douma S., Van L.T., Zevenhoven J., Meuwissen R., Van G.E., Peeper D.S. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 2004, 430:1034-1039.
61. Duda D.G., Duyverman A.M., Kohno M., Snuderl M., Steller E.J., Fukumura D., Jain R.K. Malignant cells facilitate lung metastasis by bringing their own soil. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:21677-21682.
62. Edwards L.A., Thiessen B., Dragowska W.H., Daynard T., Bally M.B., Dedhar S. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth. Oncogene 2005, 24:3596-3605.
63. Elstrom R.L., Bauer D.E., Buzzai M., Karnauskas R., Harris M.H., Plas D.R., Zhuang H., Cinalli R.M., Alavi A., Rudin C.M., Thompson C.B. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004, 64:3892-3899.
64. Felding-Habermann B., Fransvea E., O'Toole T.E., Manzuk L., Faha B., Hensler M. Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells. Clin. Exp. Metastasis 2002, 19:427-436.
65. Feng Z., Hu W., de S.E., Teresky A.K., Jin S., Lowe S., Levine A.J. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res. 2007, 67:3043-3053.
66. Flamant L., Notte A., Ninane N., Raes M., Michiels C. Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia. Mol. Cancer 2010, 9:191.
67. Freitas A.A., Rocha B. Peripheral T cell survival. Curr. Opin. Immunol. 1999, 11:152-156.
68. Friedl P. Prespecification and plasticity: shifting mechanisms of cell migration. Curr. Opin. Cell Biol. 2004, 16:14-23.
69. Friedl P., Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011, 147:992-1009.
70. Friedl P., Wolf K. Proteolytic and non-proteolytic migration of tumour cells and leucocytes. Biochem. Soc. Symp. 2003, 277-285.
71. Frisch S.M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 1994, 124:619-626.
72. Frisch S.M., Ruoslahti E. Integrins and anoikis. Curr. Opin. Cell Biol. 1997, 9:701-706.
73. Frisch S.M., Screaton R.A. Anoikis mechanisms. Curr. Opin. Cell Biol. 2001, 13:555-562.
74. Frisch S.M., Vuori K., Kelaita D., Sicks S. A role for Jun-N-terminal kinase in anoikis; suppression by bcl-2 and crmA. J. Cell Biol. 1996, 135:1377-1382.
75. Frisch S.M., Vuori K., Ruoslahti E., Chan-Hui P.Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. 1996, 134:793-799.
76. Fung C., Lock R., Gao S., Salas E., Debnath J. Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol. Biol. Cell 2008, 19:797-806.
77. Garzino-Demo P., Carrozzo M., Trusolino L., Savoia P., Gandolfo S., Marchisio P.C. Altered expression of alpha 6 integrin subunit in oral squamous cell carcinoma and oral potentially malignant lesions. Oral Oncol. 1998, 34:204-210.
78. Garzon R., Marcucci G., Croce C.M. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov. 2010, 9:775-789.
79. Gazaryan I.G., Brown A.M. Intersection between mitochondrial permeability pores and mitochondrial fusion/fission. Neurochem. Res. 2007, 32:917-929.
80. Gehlsen K.R., Davis G.E., Sriramarao P. Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin. Exp. Metastasis 1992, 10:111-120.
81. Geiger T.R., Peeper D.S. Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis. Cancer Res. 2007, 67:6221-6229.
82. Gemmill R.M., Roche J., Potiron V.A., Nasarre P., Mitas M., Coldren C.D., Helfrich B.A., Garrett-Mayer E., Bunn P.A., Drabkin H.A. ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett. 2011, 300:66-78.
83. Gheldof A., Berx G. Cadherins and epithelial-to-mesenchymal transition. Prog. Mol. Biol. Transl. Sci. 2013, 116:317-336.
84. Giancotti F.G. Complexity and specificity of integrin signalling. Nat. Cell Biol. 2000, 2:E13-E14.
85. Giancotti F.G., Ruoslahti E. Integrin signaling. Science 1999, 285:1028-1032.
86. Giannoni E., Bianchini F., Calorini L., Chiarugi P. Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. Antioxid. Redox Signal. 2011, 14:2361-2371.
87. Giannoni E., Bianchini F., Masieri L., Serni S., Torre E., Calorini P., Chiarugi P. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res. 2010, 70:6945-6956.
88. Giannoni E., Buricchi F., Grimaldi G., Parri M., Cialdai F., Taddei M.L., Raugei G., Ramponi G., Chiarugi P. Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. Cell Death Differ. 2008, 15:867-878.
89. Giannoni E., Fiaschi T., Ramponi G., Chiarugi P. Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals. Oncogene 2009, 28:2074-2086.
90. Giannoni E., Parri M., Chiarugi P. EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy. Antioxid. Redox Signal. 2012, 16:1248-1263.
91. Gibbons D.L., Lin W., Creighton C.J., Rizvi Z.H., Gregory P.A., Goodall G.J., Thilaganathan N., Du L., Zhang Y., Pertsemlidis A., Kurie J.M. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev. 2009, 23:2140-2151.
92. Gilmore A.P. Anoikis. Cell Death Differ. 2005, 12(Suppl. 2):1473-1477.
93. Gironella M., Seux M., Xie M.J., Cano C., Tomasini R., Gommeaux J., Garcia S., Nowak J., Yeung M.L., Jeang K.T., Chaix A., Fazli L., Motoo Y., Wang Q., Rocchi P., Russo A., Gleave M., Dagorn J.C., Iovanna J.L., Carrier A., Pebusque M.J., Dusetti N.J. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:16170-16175.
94. Gough D.R., Cotter T.G. Hydrogen peroxide: a Jekyll and Hyde signalling molecule. Cell Death Dis. 2011, 2:e213.
95. Grassian A.R., Schafer Z.T., Brugge J.S. ErbB2 stabilizes epidermal growth factor receptor (EGFR) expression via Erk and Sprouty2 in extracellular matrix-detached cells. J. Biol. Chem. 2011, 286:79-90.
96. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., Vadas M.A., Khew-Goodall Y., Goodall G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008, 10:593-601.
97. Groeger G., Quiney C., Cotter T.G. Hydrogen peroxide as a cell-survival signaling molecule. Antioxid. Redox Signal. 2009, 11:2655-2671.
98. Grossmann J. Molecular mechanisms of "detachment-induced apoptosis-Anoikis". Apoptosis 2002, 7:247-260.
99. Gruning N.M., Rinnerthaler M., Bluemlein K., Mulleder M., Wamelink M.M., Lehrach H., Jakobs C., Breitenbach M., Ralser M. Pyruvate kinase triggers a metabolic feedback loop that controls redox metabolism in respiring cells. Cell Metab. 2011, 14:415-427.
100. Haenssen K.K., Caldwell S.A., Shahriari K.S., Jackson S.R., Whelan K.A., Klein-Szanto A.J., Reginato M.J. ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells. J. Cell Sci. 2010, 123:1373-1382.
101. Hagen T. Oxygen versus reactive oxygen in the regulation of HIF-1alpha: the balance tips. Biochem. Res. Int. 2012, 2012:436981.
102. Halim H., Chanvorachote P. Long-term hydrogen peroxide exposure potentiates anoikis resistance and anchorage-independent growth in lung carcinoma cells. Cell Biol. Int. 2012, 36:1055-1066.
103. Haller H., Kunzendorf U., Sacherer K., Lindschau C., Walz G., Distler A., Luft F.C. T cell adhesion to P-selectin induces tyrosine phosphorylation of pp 125 focal adhesion kinase and other substrates. J. Immunol. 1997, 158:1061-1067.
104. Han J., Hou W., Goldstein L.A., Lu C., Stolz D.B., Yin X.M., Rabinowich H. Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells. J. Biol. Chem. 2008, 283:19665-19677.
105. Hannigan G., Troussard A.A., Dedhar S. Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat. Rev. Cancer 2005, 5:51-63.
106. Helbig G., Christopherson K.W., Bhat-Nakshatri P., Kumar S., Kishimoto H., Miller K.D., Broxmeyer H.E., Nakshatri H. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J. Biol. Chem. 2003, 278:21631-21638.
107. Hill L., Browne G., Tulchinsky E. ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer. Int. J. Cancer 2013, 132:745-754.
108. Horbinski C., Mojesky C., Kyprianou N. Live free or die: tales of homeless (cells) in cancer. Am. J. Pathol. 2010, 177:1044-1052.
109. Horowitz J.C., Rogers D.S., Simon R.H., Sisson T.H., Thannickal V.J. Plasminogen activation induced pericellular fibronectin proteolysis promotes fibroblast apoptosis. Am. J. Respir. Cell Mol. Biol. 2008, 38:78-87.
110. Howard E.W., Leung S.C., Yuen H.F., Chua C.W., Lee D.T., Chan K.W., Wang X., Wong Y.C. Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer. Clin. Exp. Metastasis 2008, 25:497-508.
111. Howe E.N., Cochrane D.R., Richer J.K. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res. 2011, 13:R45.
112. Huber M.A., Azoitei N., Baumann B., Grunert S., Sommer A., Pehamberger H., Kraut N., Beug H., Wirth T. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J. Clin. Invest. 2004, 114:569-581.
113. Hungerford J.E., Compton M.T., Matter M.L., Hoffstrom B.G., Otey C.A. Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J. Cell Biol. 1996, 135:1383-1390.
114. Ilic D., Almeida E.A., Schlaepfer D.D., Dazin P., Aizawa S., Damsky C.H. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J. Cell Biol. 1998, 143:547-560.
115. Imai T., Horiuchi A., Wang C., Oka K., Ohira S., Nikaido T., Konishi I. Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am. J. Pathol. 2003, 163:1437-1447.
116. Itani S., Kunisada T., Morimoto Y., Yoshida A., Sasaki T., Ito S., Ouchida M., Sugihara S., Shimizu K., Ozaki T. MicroRNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via programmed cell death protein 4 (PDCD4). J. Cancer Res. Clin. Oncol. 2012, 138:1501-1509.
117. Jan Y., Matter M., Pai J.T., Chen Y.L., Pilch J., Komatsu M., Ong E., Fukuda M., Ruoslahti E. A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors. Cell 2004, 116:751-762.
118. Janes S.M., Watt F.M. Switch from alphavbeta5 to alphavbeta6 integrin expression protects squamous cell carcinomas from anoikis. J. Cell Biol. 2004, 166:419-431.
119. Jenning S., Pham T., Ireland S.K., Ruoslahti E., Biliran H. Bit1 in anoikis resistance and tumor metastasis. Cancer Lett. 2013, 333:147-151.
120. Jeon S.M., Chandel N.S., Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 2012, 485:661-665.
121. Jung C.H., Ro S.H., Cao J., Otto N.M., Kim D.H. mTOR regulation of autophagy. FEBS Lett. 2010, 584:1287-1295.
122. Kamarajugadda S., Stemboroski L., Cai Q., Simpson N.E., Nayak S., Tan M., Lu J. Glucose oxidation modulates anoikis and tumor metastasis. Mol. Cell Biol. 2012, 32:1893-1907.
123. Kantak S.S., Kramer R.H. E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J. Biol. Chem. 1998, 273:16953-16961.
124. Karin M., Cao Y., Greten F.R., Li Z.W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2002, 2:301-310.
125. Karin M., Lin A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 2002, 3:221-227.
126. Keith B., Johnson R.S., Simon M.C. HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat. Rev. Cancer 2012, 12:9-22.
127. Khwaja A., Rodriguez-Viciana P., Wennstrom S., Warne P.H., Downward J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 1997, 16:2783-2793.
128. Kim J., Kundu M., Viollet B., Guan K.L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 2011, 13:132-141.
129. Kim T., Veronese A., Pichiorri F., Lee T.J., Jeon Y.J., Volinia S., Pineau P., Marchio A., Palatini J., Suh S.S., Alder H., Liu C.G., Dejean A., Croce C.M. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J. Exp. Med. 2011, 208:875-883.
130. Kim W., Kook S., Kim D.J., Teodorof C., Song W.K. The 31-kDa caspase-generated cleavage product of p130cas functions as a transcriptional repressor of E2A in apoptotic cells. J. Biol. Chem. 2004, 279:8333-8342.
131. Kong W., Yang H., He L., Zhao J.J., Coppola D., Dalton W.S., Cheng J.Q. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell Biol. 2008, 28:6773-6784.
132. Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007, 87:99-163.
133. Kumarswamy R., Mudduluru G., Ceppi P., Muppala S., Kozlowski M., Niklinski J., Papotti M., Allgayer H. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer. Int. J. Cancer 2012, 130:2044-2053.
134. Kurrey N.K., Jalgaonkar S.P., Joglekar A.V., Ghanate A.D., Chaskar P.D., Doiphode R.Y., Bapat S.A. Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 2009, 27:2059-2068.
135. Kuwana T., Bouchier-Hayes L., Chipuk J.E., Bonzon C., Sullivan B.A., Green D.R., Newmeyer D.D. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol. Cell 2005, 17:525-535.
136. Kwok W.K., Ling M.T., Lee T.W., Lau T.C., Zhou C., Zhang X., Chua C.W., Chan K.W., Chan F.L., Glackin C., Wong Y.C., Wang X. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res. 2005, 65:5153-5162.
137. Langley R.R., Fidler I.J. The seed and soil hypothesis revisited-the role of tumor-stroma interactions in metastasis to different organs. Int. J. Cancer 2011, 128:2527-2535.
138. Le Gall M., Chambard J.C., Breittmayer J.P., Grall D., Pouyssegur J., Obberghen-Schilling E. The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal. Mol. Biol. Cell 2000, 11:1103-1112.
139. Lester R.D., Jo M., Montel V., Takimoto S., Gonias S.L. uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. J. Cell Biol. 2007, 178:425-436.
140. Letai A., Bassik M.C., Walensky L.D., Sorcinelli M.D., Weiler S., Korsmeyer S.J. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2002, 2:183-192.
141. Ley R., Ewings K.E., Hadfield K., Cook S.J. Regulatory phosphorylation of Bim: sorting out the ERK from the JNK. Cell Death Differ. 2005, 12:1008-1014.
142. Li Y., Paonessa J.D., Zhang Y. Mechanism of chemical activation of Nrf2. PLoS One 2012, 7:e35122.
143. Li Y.M., Zhou B.P., Deng J., Pan Y., Hay N., Hung M.C. A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells. Cancer Res. 2005, 65:3257-3263.
144. Lietha D., Cai X., Ceccarelli D.F., Li Y., Schaller M.D., Eck M.J. Structural basis for the autoinhibition of focal adhesion kinase. Cell 2007, 129:1177-1187.
145. Lizcano J.M., Morrice N., Cohen P. Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochem. J. 2000, 349:547-557.
146. Locasale J.W., Cantley L.C. Altered metabolism in cancer. BMC Biol. 2010, 8:88.
147. Lock R., Roy S., Kenific C.M., Su J.S., Salas E., Ronen S.M., Debnath J. Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol. Biol. Cell 2011, 22:165-178.
148. Luce K., Weil A.C., Osiewacz H.D. Mitochondrial protein quality control systems in aging and disease. Adv. Exp. Med. Biol. 2010, 694:108-125.
149. Luo W., Hu H., Chang R., Zhong J., Knabel M., O'Meally R., Cole R.N., Pandey A., Semenza G.L. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 2011, 145:732-744.
150. Marani M., Hancock D., Lopes R., Tenev T., Downward J., Lemoine N.R. Role of Bim in the survival pathway induced by Raf in epithelial cells. Oncogene 2004, 23:2431-2441.
151. Mareel M.M., Van Roy F.M., De B.P. The invasive phenotypes. Cancer Metastasis Rev. 1990, 9:45-62.
152. Mateescu B., Batista L., Cardon M., Gruosso T., de F.Y., Mariani O., Nicolas A., Meyniel J.P., Cottu P., Sastre-Garau X., Mechta-Grigoriou F. MiR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat. Med. 2011, 17:1627-1635.
153. Matoba S., Kang J.G., Patino W.D., Wragg A., Boehm M., Gavrilova O., Hurley P.J., Bunz F., Hwang P.M. p53 regulates mitochondrial respiration. Science 2006, 312:1650-1653.
154. Matter M.L., Zhang Z., Nordstedt C., Ruoslahti E. The alpha5beta1 integrin mediates elimination of amyloid-beta peptide and protects against apoptosis. J. Cell Biol. 1998, 141:1019-1030.
155. Mercurio A.M., Bachelder R.E., Chung J., O'Connor K.L., Rabinovitz I., Shaw L.M., Tani T. Integrin laminin receptors and breast carcinoma progression. J. Mammary Gland Biol. Neoplasia 2001, 6:299-309.
156. Mimeault M., Batra S.K. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells. J. Cell. Mol. Med. 2013, 17:30-54.
157. Morito N., Yoh K., Itoh K., Hirayama A., Koyama A., Yamamoto M., Takahashi S. Nrf2 regulates the sensitivity of death receptor signals by affecting intracellular glutathione levels. Oncogene 2003, 22:9275-9281.
158. Moro L., Dolce L., Cabodi S., Bergatto E., Boeri E.E., Smeriglio M., Turco E., Retta S.F., Giuffrida M.G., Venturino M., Godovac-Zimmermann J., Conti A., Schaefer E., Beguinot L., Tacchetti C., Gaggini P., Silengo L., Tarone G., Defilippi P. Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines. J. Biol. Chem. 2002, 277:9405-9414.
159. Moro L., Venturino M., Bozzo C., Silengo L., Altruda F., Beguinot L., Tarone G., Defilippi P. Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. EMBO J. 1998, 17:6622-6632.
160. Morozevich G.E., Kozlova N.I., Chubukina A.N., Berman A.E. Role of integrin alphavbeta3 in substrate-dependent apoptosis of human intestinal carcinoma cells. Biochemistry 2003, 68:416-423.
161. Muzio M., Stockwell B.R., Stennicke H.R., Salvesen G.S., Dixit V.M. An induced proximity model for caspase-8 activation. J. Biol. Chem. 1998, 273:2926-2930.
162. Nakano K., Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 2001, 7:683-694.
163. O'Brien V., Frisch S.M., Juliano R.L. Expression of the integrin alpha 5 subunit in HT29 colon carcinoma cells suppresses apoptosis triggered by serum deprivation. Exp. Cell Res. 1996, 224:208-213.
164. Ohira T., Gemmill R.M., Ferguson K., Kusy S., Roche J., Brambilla E., Zeng C., Baron A., Bemis L., Erickson P., Wilder E., Rustgi A., Kitajewski J., Gabrielson E., Bremnes R., Franklin W., Drabkin H.A. WNT7a induces E-cadherin in lung cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:10429-10434.
165. Orford K., Orford C.C., Byers S.W. Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. J. Cell Biol. 1999, 146:855-868.
166. Osada-Oka M., Hashiba Y., Akiba S., Imaoka S., Sato T. Glucose is necessary for stabilization of hypoxia-inducible factor-1alpha under hypoxia: contribution of the pentose phosphate pathway to this stabilization. FEBS Lett. 2010, 584:3073-3079.
167. Pani G., Giannoni E., Galeotti T., Chiarugi P. Redox-based escape mechanism from death: the cancer lesson. Antioxid. Redox Signal. 2009, 11:2791-2806.
168. Parri M., Chiarugi P. Redox molecular machines involved in tumor progression. Antioxid. Redox Signal. 2013.
169. Parsons S.J., Parsons J.T. Src family kinases, key regulators of signal transduction. Oncogene 2004, 23:7906-7909.
170. Persad S., Attwell S., Gray V., Delcommenne M., Troussard A., Sanghera J., Dedhar S. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:3207-3212.
171. Peshavariya H., Dusting G.J., Jiang F., Halmos L.R., Sobey C.G., Drummond G.R., Selemidis S. NADPH oxidase isoform selective regulation of endothelial cell proliferation and survival. Naunyn Schmiedebergs Arch. Pharmacol. 2009, 380:193-204.
172. Pike L.R., Phadwal K., Simon A.K., Harris A.L. ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia. Mol. Biol. Rep. 2012, 39:10811-10822.
173. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 2009, 9:265-273.
174. Puthalakath H., Huang D.C., O'Reilly L.A., King S.M., Strasser A. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell 1999, 3:287-296.
175. Puthalakath H., Villunger A., O'Reilly L.A., Beaumont J.G., Coultas L., Cheney R.E., Huang D.C., Strasser A. Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science 2001, 293:1829-1832.
176. Qi X.J., Wildey G.M., Howe P.H. Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function. J. Biol. Chem. 2006, 281:813-823.
177. Radisky D.C. MiR-200c at the nexus of epithelial-mesenchymal transition, resistance to apoptosis, and the breast cancer stem cell phenotype. Breast Cancer Res. 2011, 13:110.
178. Ramanathan B., Jan K.Y., Chen C.H., Hour T.C., Yu H.J., Pu Y.S. Resistance to paclitaxel is proportional to cellular total antioxidant capacity. Cancer Res. 2005, 65:8455-8460.
179. Ramos D.M., But M., Regezi J., Schmidt B.L., Atakilit A., Dang D., Ellis D., Jordan R., Li X. Expression of integrin beta 6 enhances invasive behavior in oral squamous cell carcinoma. Matrix Biol. 2002, 21:297-307.
180. Reddig P.J., Juliano R.L. Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev. 2005, 24:425-439.
181. Reginato M.J., Mills K.R., Paulus J.K., Lynch D.K., Sgroi D.C., Debnath J., Muthuswamy S.K., Brugge J.S. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat. Cell Biol. 2003, 5:733-740.
182. Romashkova J.A., Makarov S.S. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999, 401:86-90.
183. Rosen K., Shi W., Calabretta B., Filmus J. Cell detachment triggers p38 mitogen-activated protein kinase-dependent overexpression of Fas ligand. A novel mechanism of Anoikis of intestinal epithelial cells. J. Biol. Chem. 2002, 277:46123-46130.
184. Royer C., Lachuer J., Crouzoulon G., Roux J., Peyronnet J., Mamet J., Pequignot J., Dalmaz Y. Effects of gestational hypoxia on mRNA levels of Glut3 and Glut4 transporters, hypoxia inducible factor-1 and thyroid hormone receptors in developing rat brain. Brain Res. 2000, 856:119-128.
185. Rungtabnapa P., Nimmannit U., Halim H., Rojanasakul Y., Chanvorachote P. Hydrogen peroxide inhibits non-small cell lung cancer cell anoikis through the inhibition of caveolin-1 degradation. Am. J. Physiol. Cell Physiol. 2011, 300:C235-C245.
186. Sade H., Sarin A. Reactive oxygen species regulate quiescent T-cell apoptosis via the BH3-only proapoptotic protein BIM. Cell Death Differ. 2004, 11:416-423.
187. Sahai E., Marshall C.J. RHO-GTPases and cancer. Nat. Rev. Cancer 2002, 2:133-142.
188. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., Debatin K.M., Krammer P.H., Peter M.E. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998, 17:1675-1687.
189. Schafer Z.T., Grassian A.R., Song L., Jiang Z., Gerhart-Hines Z., Irie H.Y., Gao S., Puigserver P., Brugge J.S. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 2009, 461:109-113.
190. Schaller M.D. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim. Biophys. Acta 2001, 1540:1-21.
191. Schlaepfer D.D., Broome M.A., Hunter T. Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins. Mol. Cell Biol. 1997, 17:1702-1713.
192. Schlaepfer D.D., Hanks S.K., Hunter T., van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994, 372:786-791.
193. Schlaepfer D.D., Hauck C.R., Sieg D.J. Signaling through focal adhesion kinase. Prog. Biophys. Mol. Biol. 1999, 71:435-478.
194. Schlaepfer D.D., Hunter T. Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases. Mol. Cell Biol. 1996, 16:5623-5633.
195. Schlaepfer D.D., Hunter T. Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src. J. Biol. Chem. 1997, 272:13189-13195.
196. Schmalhofer O., Brabletz S., Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev. 2009, 28:151-166.
197. Schneller M., Vuori K., Ruoslahti E. Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. EMBO J. 1997, 16:5600-5607.
198. Semenza G.L., Jiang B.H., Leung S.W., Passantino R., Concordet J.P., Maire P., Giallongo A. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 1996, 271:32529-32537.
199. Sermeus A., Cosse J.P., Crespin M., Mainfroid V., de L.F., Ninane N., Raes M., Remacle J., Michiels C. Hypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activity. Mol. Cancer 2008, 7:27.
200. Sermeus A., Genin M., Maincent A., Fransolet M., Notte A., Leclere L., Riquier H., Arnould T., Michiels C. Hypoxia-induced modulation of apoptosis and BCL-2 family proteins in different cancer cell types. PLoS One 2012, 7:e47519.
201. Sharma S.V., Bell D.W., Settleman J., Haber D.A. Epidermal growth factor receptor mutations in lung cancer. Nat. Rev. Cancer 2007, 7:169-181.
202. Shen X., Kramer R.H. Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor. Am. J. Pathol. 2004, 165:1315-1329.
203. Shibue T., Takeda K., Oda E., Tanaka H., Murasawa H., Takaoka A., Morishita Y., Akira S., Taniguchi T., Tanaka N. Integral role of Noxa in p53-mediated apoptotic response. Genes Dev. 2003, 17:2233-2238.
204. Shim S.R., Kook S., Kim J.I., Song W.K. Degradation of focal adhesion proteins paxillin and p130cas by caspases or calpains in apoptotic rat-1 and L929 cells. Biochem. Biophys. Res. Commun. 2001, 286:601-608.
205. Shimamura A., Ballif B.A., Richards S.A., Blenis J. Rsk1 mediates a MEK-MAP kinase cell survival signal. Curr. Biol. 2000, 10:127-135.
206. Shimizu S., Narita M., Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999, 399:483-487.
207. Singh S., Chitkara D., Mehrazin R., Behrman S.W., Wake R.W., Mahato R.I. Chemoresistance in prostate cancer cells is regulated by miRNAs and Hedgehog pathway. PLoS One 2012, 7:e40021.
208. Smit M.A., Geiger T.R., Song J.Y., Gitelman I., Peeper D.S. A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol. Cell Biol. 2009, 29:3722-3737.
209. Soldi R., Mitola S., Strasly M., Defilippi P., Tarone G., Bussolino F. Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J. 1999, 18:882-892.
210. Songserm T., Pongrakhananon V., Chanvorachote P. Sub-toxic cisplatin mediates anoikis resistance through hydrogen peroxide-induced caveolin-1 up-regulation in non-small cell lung cancer cells. Anticancer Res. 2012, 32:1659-1669.
211. Sosa M.S., Bragado P., Debnath J., Aguirre-Ghiso J.A. Regulation of tumor cell dormancy by tissue microenvironments and autophagy. Adv. Exp. Med. Biol. 2013, 734:73-89.
212. Sreekumar R., Sayan B.S., Mirnezami A.H., Sayan A.E. MicroRNA control of invasion and metastasis pathways. Front. Genet. 2011, 2:58.
213. Stambolic V., MacPherson D., Sas D., Lin Y., Snow B., Jang Y., Benchimol S., Mak T.W. Regulation of PTEN transcription by p53. Mol. Cell 2001, 8:317-325.
214. Stinson S., Lackner M.R., Adai A.T., Yu N., Kim H.J., O'Brien C., Spoerke J., Jhunjhunwala S., Boyd Z., Januario T., Newman R.J., Yue P., Bourgon R., Modrusan Z., Stern H.M., Warming S., de Sauvage F.J., Amler L., Yeh R.F., Dornan D. MiR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer. Sci. Signal. 2011, 4:p.t5.
215. Sun S., Ning X., Zhang Y., Lu Y., Nie Y., Han S., Liu L., Du R., Xia L., He L., Fan D. Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int. 2009, 75:1278-1287.
216. Sundberg C., Rubin K. Stimulation of beta1 integrins on fibroblasts induces PDGF independent tyrosine phosphorylation of PDGF beta-receptors. J. Cell Biol. 1996, 132:741-752.
217. Taddei M.L., Giannoni E., Fiaschi T., Chiarugi P. Anoikis: an emerging hallmark in health and diseases. J. Pathol. 2012, 226:380-393.
218. Taddei M.L., Parri M., Angelucci A., Bianchini F., Marconi C., Giannoni E., Raugei G., Bologna M., Calorini L., Chiarugi P. EphA2 induces metastatic growth regulating amoeboid motility and clonogenic potential in prostate carcinoma cells. Mol. Cancer Res. 2011, 9:149-160.
219. Takeyama Y., Sato M., Horio M., Hase T., Yoshida K., Yokoyama T., Nakashima H., Hashimoto N., Sekido Y., Gazdar A.F., Minna J.D., Kondo M., Hasegawa Y. Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells. Cancer Lett. 2010, 296:216-224.
220. Tanaka K., Mohri Y., Nishioka J., Kobayashi M., Ohi M., Miki C., Tonouchi H., Nobori T., Kusunoki M. Neurotrophic receptor, tropomyosin-related kinase B as an independent prognostic marker in gastric cancer patients. J. Surg. Oncol. 2009, 99:307-310.
221. Taylor R.C., Cullen S.P., Martin S.J. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 2008, 9:231-241.
222. Terada L.S., Nwariaku F.E. Escaping anoikis through ROS: ANGPTL4 controls integrin signaling through Nox1. Cancer Cell 2011, 19:297-299.
223. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7:131-142.
224. Thornberry N.A. Caspases: key mediators of apoptosis. Chem. Biol. 1998, 5:R97-R103.
225. Tokunaga E., Oki E., Egashira A., Sadanaga N., Morita M., Kakeji Y., Maehara Y. Deregulation of the Akt pathway in human cancer. Curr. Cancer Drug Targets 2008, 8:27-36.
226. Trachootham D., Lu W., Ogasawara M.A., Nilsa R.D., Huang P. Redox regulation of cell survival. Antioxid. Redox Signal. 2008, 10:1343-1374.
227. Tryndyak V.P., Beland F.A., Pogribny I.P. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Int. J. Cancer 2010, 126:2575-2583.
228. Tsai Y.P., Wu K.J. Hypoxia-regulated target genes implicated in tumor metastasis. J. Biomed. Sci. 2012, 19:102.
229. Uttamsingh S., Bao X., Nguyen K.T., Bhanot M., Gong J., Chan J.L., Liu F., Chu T.T., Wang L.H. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene 2008, 27:2626-2634.
230. Valentijn A.J., Gilmore A.P. Translocation of full-length Bid to mitochondria during anoikis. J. Biol. Chem. 2004, 279:32848-32857.
231. Vander Heiden M.G., Chandel N.S., Williamson E.K., Schumacker P.T., Thompson C.B. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 1997, 91:627-637.
232. Varadhachary A.S., Edidin M., Hanlon A.M., Peter M.E., Krammer P.H., Salgame P. Phosphatidylinositol 3'-kinase blocks CD95 aggregation and caspase-8 cleavage at the death-inducing signaling complex by modulating lateral diffusion of CD95. J. Immunol. 2001, 166:6564-6569.
233. Virdee K., Parone P.A., Tolkovsky A.M. Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival. Curr. Biol. 2000, 10:1151-1154.
234. Vitolo M.I., Weiss M.B., Szmacinski M., Tahir K., Waldman T., Park B.H., Martin S.S., Weber D.J., Bachman K.E. Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells. Cancer Res. 2009, 69:8275-8283.
235. Wajant H. The Fas signaling pathway: more than a paradigm. Science 2002, 296:1635-1636.
236. Wang C.Z., Hsu Y.M., Tang M.J. Function of discoidin domain receptor I in HGF-induced branching tubulogenesis of MDCK cells in collagen gel. J. Cell. Physiol. 2005, 203:295-304.
237. Ward P.S., Thompson C.B. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 2012, 21:297-308.
238. Wary K.K., Mariotti A., Zurzolo C., Giancotti F.G. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 1998, 94:625-634.
239. Wey J.S., Gray M.J., Fan F., Belcheva A., McCarty M.F., Stoeltzing O., Somcio R., Liu W., Evans D.B., Klagsbrun M., Gallick G.E., Ellis L.M. Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. Br. J. Cancer 2005, 93:233-241.
240. Wheaton W.W., Chandel N.S. Hypoxia. 2. Hypoxia regulates cellular metabolism. Am. J. Physiol. Cell Physiol. 2011, 300:C385-C393.
241. Whelan K.A., Caldwell S.A., Shahriari K.S., Jackson S.R., Franchetti L.D., Johannes G.J., Reginato M.J. Hypoxia suppression of Bim and Bmf blocks anoikis and luminal clearing during mammary morphogenesis. Mol. Biol. Cell 2010, 21:3829-3837.
242. Widmann C., Gibson S., Johnson G.L. Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J. Biol. Chem. 1998, 273:7141-7147.
243. Wolf K., Muller R., Borgmann S., Brocker E.B., Friedl P. Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood 2003, 102:3262-3269.
244. Wu C. ILK interactions. J. Cell Sci. 2001, 114:2549-2550.
245. Wu Y., Deng J., Rychahou P.G., Qiu S., Evers B.M., Zhou B.P. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 2009, 15:416-428.
246. Wu Y., Zhou B.P. Snail: more than EMT. Cell Adh. Migr. 2010, 4:199-203.
247. Xia H., Nho R.S., Kahm J., Kleidon J., Henke C.A. Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta 1 integrin viability signaling pathway. J. Biol. Chem. 2004, 279:33024-33034.
248. Yamaguchi H., Wyckoff J., Condeelis J. Cell migration in tumors. Curr. Opin. Cell Biol. 2005, 17:559-564.
249. Yamaki N., Negishi M., Katoh H. RhoG regulates anoikis through a phosphatidylinositol 3-kinase-dependent mechanism. Exp. Cell Res. 2007, 313:2821-2832.
250. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., Savagner P., Gitelman I., Richardson A., Weinberg R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939.
251. Yeung S.J., Pan J., Lee M.H. Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer. Cell. Mol. Life Sci. 2008, 65:3981-3999.
252. Yu S.J., Hu J.Y., Kuang X.Y., Luo J.M., Hou Y.F., Di G.H., Wu J., Shen Z.Z., Song H.Y., Shao Z.M. MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer. Clin. Cancer Res. 2013, 19:1389-1399.
253. Yu X., Cohen D.M., Chen C.S. MiR-125b is an adhesion-regulated microRNA that protects mesenchymal stem cells from anoikis. Stem Cells 2012, 30:956-964.
254. Yu X., Liu L., Cai B., He Y., Wan X. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer. Cancer Sci. 2008, 99:543-552.
255. Yu X., Miyamoto S., Mekada E. Integrin alpha 2 beta 1-dependent EGF receptor activation at cell-cell contact sites. J. Cell Sci. 2000, 113(Pt 12):2139-2147.
256. Zhang H., Bosch-Marce M., Shimoda L.A., Tan Y.S., Baek J.H., Wesley J.B., Gonzalez F.J., Semenza G.L. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem. 2008, 283:10892-10903.
257. Zhang Y., Fujiwara Y., Doki Y., Takiguchi S., Yasuda T., Miyata H., Yamazaki M., Ngan C.Y., Yamamoto H., Ma Q., Monden M. Overexpression of tyrosine kinase B protein as a predictor for distant metastases and prognosis in gastric carcinoma. Oncology 2008, 75:17-26.
258. Zhang Y.H., Wu Y.L., Tashiro S., Onodera S., Ikejima T. Reactive oxygen species contribute to oridonin-induced apoptosis and autophagy in human cervical carcinoma HeLa cells. Acta Pharmacol Sin 2011, 32:1266-1275.
259. Zhang Y., Qi H., Taylor R., Xu W., Liu L.F., Jin S. The role of autophagy in mitochondria maintenance: characterization of mitochondrial functions in autophagy-deficient S. cerevisiae strains. Autophagy 2007, 3:337-346.
260. Zhang Y.F., Zhang A.R., Zhang B.C., Rao Z.G., Gao J.F., Lv M.H., Wu Y.Y., Wang S.M., Wang R.Q., Fang D.C. MiR-26a regulates cell cycle and anoikis of human esophageal adenocarcinoma cells through Rb1-E2F1 signaling pathway. Mol. Biol. Rep. 2013, 40:1711-1720.
261. Zhang Z., Vuori K., Reed J.C., Ruoslahti E. The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:6161-6165.
262. Zhao D., Tang X.F., Yang K., Liu J.Y., Ma X.R. Over-expression of integrin-linked kinase correlates with aberrant expression of Snail, E-cadherin and N-cadherin in oral squamous cell carcinoma: implications in tumor progression and metastasis. Clin. Exp. Metastasis 2012, 29:957-969.
263. Zheng D.Q., Woodard A.S., Fornaro M., Tallini G., Languino L.R. Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway. Cancer Res. 1999, 59:1655-1664.
264. Zhou F., Yang Y., Xing D. Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS J. 2011, 278:403-413.
265. Zhu J., Pan X., Zhang Z., Gao J., Zhang L., Chen J. Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells. Cell. Signal. 2012, 24:1323-1332.
266. Zou H., Henzel W.J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997, 90:405-413.